Search Results - "Lainscak, M."

The Slovenian version of the Cardiac depression scale – validity and reliability by Palandacic, A Kokalj, Ucman, S, Lainscak, M, Novak Sarotar, B

“…IntroductionCardiovascular diseases (CVD) were the cause of 40% of all deaths in Slovenia in 2016, and are the seventh most common cause of visits to the…”
Get full text

The manifestation of anxiety in patients undergoing elective coronary angiography by Kokalj Palandacic, A., Ucman, S., Novak Sarotar, B., Lainscak, M.

“…Introduction Prevalence of anxiety disorders in coronary artery disease reaches up to 15% and about half of patients with coronary artery disease have anxiety…”
Get full text

Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD) by Leermakers, P. A., Schols, A. M. W. J., Kneppers, A. E. M., Kelders, M. C. J. M., de Theije, C. C., Lainscak, M., Gosker, H. R.

“…Loss of skeletal muscle mitochondrial oxidative capacity is well-established in patients with COPD, but the role of mitochondrial breakdown herein is largely…”
Get full text

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study by Tavazzi, L, Swedberg, K, Komajda, M, Böhm, M, Borer, J.S, Lainscak, M, Robertson, M, Ford, I

“…Abstract Background Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently coexist, with undefined prognostic and therapeutic…”
Get full text

Impact of the β1-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients by Rau, T, Düngen, H-D, Edelmann, F, Waagstein, F, Lainščak, M, Dimković, S, Apostolović, S, Nešković, A N, Haverkamp, W, Gelbrich, G, Eschenhagen, T

“…This pharmacogenetic substudy of the prospective, double‐blind, randomized CIBIS‐ELD trial determined the impact of the β1‐adrenoceptor Arg189Gly polymorphism…”
Get full text

MON-PP174: Evaluation of Nutritional Status with Six Nutrition Screening Tools and Bioimpedance in Hospitalized Patients by Lainscak, M, Schols, A, Kosten, T, Krznaric, Z

Get full text

Request for regulatory guidance for cancer cachexia intervention trials by Fearon, KCH, Argiles, JM, Baracos, VE, Bernabei, R, Coats, AJS, Crawford, J, Deutz, NE, Doehner, W, Evans, WJ, Ferrucci, L, Garcia, JM, Gralla, RJ, Jatoi, A, Kalantar‐Zadeh, K, Lainscak, M, Morley, JE, Muscaritoli, M, Polkey, MI, Rosano, G, Rossi‐Fanelli, F, Schols, AM, Strasser, F, Vellas, B, Haehling, S, Anker, SD

“…In the last 10 years, some regulatory authorities have consistently suggested that the design of randomized controlled trials testing treatments for cachexia…”
Get full text

Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis by Szabó, T, Scherbakov, N, Sandek, A, Kung, T, von Haehling, S, Lainscak, M, Jankowska, E.A, Rudovich, N, Anker, S.D, Frystyk, J, Flyvbjerg, A, Pfeiffer, A.F.H, Doehner, W

“…Abstract Background and aims Adiponectin (ADPN) as an adipose tissue hormone contributes to regulation of energy metabolism and body composition and is…”
Get full text

Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry (vol 22, pg 92, 2020) by Lainscak, M, Milinkovic, I, Polovina, M, Crespo-Leiro, MG, Lund, LH, Anker, SD, Laroche, C, Ferrari, R, Coats, AJ, McDonagh, T, Filippatos, G, Maggioni, AP, Piepoli, MF, Rosano, GM, Ruschitzka, F, Simic, D, Asanin, M, Eicher, JC, Yilmaz, MB, Seferovic, PM

Get full text

Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology (vol 22, pg 1315, 2020) by Chioncel, O, Parissis, J, Mebazaa, A, Thiele, H, Desch, S, Bauersachs, J, Harjola, VP, Antohi, EL, Arrigo, M, Gal, TB, Celutkiene, J, Collins, SP, DeBacker, D, Iliescu, VA, Jankowska, E, Jaarsma, T, Keramida, K, Lainscak, M, Lund, LH, Lyon, AR, Masip, J, Metra, M, Miro, O, Mortara, A, Mueller, C, Mullens, W, Nikolaou, M, Piepoli, M, Price, S, Rosano, G, Vieillard-Baron, A, Weinstein, JM, Anker, SD, Filippatos, G, Ruschitzka, F, Coats, AJS, Seferovic, P

Get full text

Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure by Loncar, G., Bozic, B., Cvetinovic, N., Dungen, H.-D., Lainscak, M., von Haehling, S., Doehner, W., Radojicic, Z., Putnikovic, B., Trippel, T., Popovic, V.

“…Aim Evaluation of secondary hyperparathyroidism (SHPT) and its prognostic impact on all-cause mortality in elderly males with heart failure (HF). Methods…”
Get full text

OP040: Metabolic Syndrome, Diabetes and Body Composition in COPD Patients on Rehabilitation by Cebron Lipovec, N, Kosten, T, Omersa, D, Lainscak, M

Get full text

LB016-MON NUTRITIONAL STATUS AND BODY COMPOSITION IN CHRONIC CARDIOPULMONARY DISEASE by Cebron Lipovec, N, Cvan Trobec, K, Kosten, T, Lainscak, M

Get full text

POS-328 THE BURDEN OF HYPERKALEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT by JAMES, G., Carrero, J.J., Kumar, S., Fishbane, S., Wittbrodt, E., Kanda, E., Hedman, K., Kashihara, N., Kosiborod, M., Lainscak, M., Lam, C., Pollock, C., Stenvinkel, P., Wheeler, D.C., Pecoits-Filho, R.

Get full text

POS-503 EVALUATING CHRONIC KIDNEY DISEASE PROGRESSION: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT by ABDUL SULTAN, A., Heerspink, H., Arnold, M., Pollock, C., Garcia Sanchez, J.J., Carrero, J.J., Pecoits-Filho, R., Lam, C., Kashihara, N., Kanda, E., Kosiborod, M., Fishbane, S., Lainscak, M., Stenvinkel, P., Wheeler, D.C.

Get full text

POS-329 TREATMENT PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT by JAMES, G., Carrero, J.J., Kumar, S., Fishbane, S., Wittbrodt, E., Kanda, E., Hedman, K., Kashihara, N., Kosiborod, M., Lainscak, M., Lam, C., Pollock, C., Stenvinkel, P., Wheeler, D.C., Pecoits-Filho, R.

Get full text

LB023-MON SELF-RATED HEALTH, NUTRITIONAL STATUS AND NUTRITIONAL INTAKE PREDICT IN-HOSPITAL MORTALITY IN ADULT HOSPITALIZED PATIENTS: RESULTS OF A EUROPEAN-WIDE NUTRITIONDAY SURVEY by Lainscak, M, Farkas, J, Frantal, S, Singer, P, Hiesmayr, M, Schindler, K

Get full text

NT-proBNP predicts the need for ventilatory support in the patients with acute exacerbation of chronic obstructive pulmonary disease by Kuharic, J, Sustic, A, Marcun, R, Lainscak, M

“…Issue Title: ESICM LIVES 2015…”
Get full text

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial) by Böhm, Michael, MD, Robertson, Michele, BSc, Ford, Ian, PhD, Borer, Jeffrey S., MD, Komajda, Michel, MD, Kindermann, Ingrid, MD, Maack, Christoph, MD, Lainscak, Mitja, MD, Swedberg, Karl, MD, Tavazzi, Luigi, MD

“…Incidence of chronic heart failure (HF) increases with age and cardiovascular (CV) morbidity. Co-morbidities increase hospitalization and mortality in HF, and…”
Get full text

Effect of selective and non-selective β-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure by Kovačić, Dragan, Marinšek, Matej, Gobec, Lidija, Lainščak, Mitja, Podbregar, Matej

“…Background Chronic heart failure (CHF) is characterized by increased insulin resistance and hyperleptinaemia. We aimed to study effects of selective and…”
Get full text